Learn More
Medchemexpress LLC BI 224436 | 1155419-89-8 | 99.7% | 442.51 | 50 MG

Supplier: Medchemexpress LLC HY1859550MG
BI 224436 is a novel HIV-1 noncatalytic site integrase inhibitor. It exhibits EC50 values of less than 15 nM against different HIV-1 laboratory strains. Originally designed by Boehringer Ingelheim, this compound is suitable for various laboratory research applications.
- Novel HIV-1 noncatalytic site integrase inhibitor
- Effective against different HIV-1 laboratory strains with EC50 values less than 15 nM
- Displays an additive effect in combination with most approved antiretrovirals
- Retains full antiviral activity against recombinant viruses encoding INSTI resistance substitutions
- Exhibits excellent pharmacokinetic profiles in rat, monkey, and dog
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.